Response: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 different conditioning regimens

Схожие документы

• A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
  по: Rodriguez, Roberto, et al.
  Опубликовано: (2010)
• Thrombotic microangiopathy associated with sirolimus levels following allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based GVHD prophylaxis
  по: Shayani, Sepideh, et al.
  Опубликовано: (2012)
• Mycophenolate Mofetil-Based Salvage as Acute GVHD Prophylaxis after Early Discontinuation of Tacrolimus and/or Sirolimus
  по: Ali, Haris, et al.
  Опубликовано: (2014)
• Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
  по: Nakamura, Ryotaro, et al.
  Опубликовано: (2012)
• Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
  по: Cutler, Corey, et al.
  Опубликовано: (2014)